-
GSK and Bharat Biotech to Cut Malaria Vaccine Cost
GSK
GSK and Bharat Biotech plan to reduce the cost of Mosquirix, the world’s first WHO-approved malaria vaccine, to under $5 per dose by 2028, aiming to expand global access and support Gavi’s child immunization goals across Africa.
-
BioNTech Acquires CureVac in $1.25B mRNA Deal
BioNTech
BioNTech acquires CureVac in a $1.25 billion all-stock deal, expanding its mRNA cancer therapy pipeline and resolving ongoing litigation. The acquisition strengthens BioNTech’s oncology strategy and manufacturing capabilities.
-
Kennedy Overhauls CDC Vaccine Committee
HHS
HHS Secretary Robert F. Kennedy Jr. has disbanded the CDC’s vaccine advisory panel, citing conflicts of interest. The sweeping changes raise concerns across the healthcare and pharmaceutical industries.
-
-
五指山市|
吕梁市|
万盛区|
梧州市|
招远市|
双鸭山市|
拜泉县|
广灵县|
迭部县|
安仁县|
曲阜市|
康保县|
天峨县|
肥乡县|
平江县|
叶城县|
芦溪县|
剑河县|
宁城县|
汨罗市|
高尔夫|
石首市|
白河县|
松阳县|
上思县|
玛沁县|
呼伦贝尔市|
友谊县|
桂东县|
比如县|
香港|
中超|
郎溪县|
旬邑县|
饶阳县|
兰溪市|
许昌县|
玉溪市|
新晃|
神木县|
前郭尔|